Dr. Monica Mallampalli a patient with sleep apnea, a trained biomedical scientist and the President & CEO of the Alliance of Sleep Apnea Partners (ASAP). Having experienced challenges in treatment, following her diagnosis with obstructive sleep apnea a decade ago led her to her current role at ASAP in advocating for those who suffer from sleep apnea. Besides being a patient advocate, she also bring unique perspectives to conversations or discussions with research and health policy experience based on her 15+ policy advocacy experience. Dr. Mallampalli was recently appointed to the American Academy of Sleep Medicine's (AASM) Women and Sleep Health Task Force.

Jennifer L. Martin is Endowed Professor and Director of the Benjamin Leon Jr. Family Center for Aging Research and Education at Florida International University, and Director of the Miami VA Healthcare System Geriatric Research, Education and Clinical Center. Dr. Martin’s scientific research program focuses on improving sleep as a key component of maintaining and improving physical and mental health in older adults, women, and Veterans. Her work has been supported by NIH, VA, industry and non-profit foundations. Core areas of her work include developing and testing novel approaches to treating insomnia disorder, improving use of sleep apnea treatments, and understanding how improved sleep leads to health benefits. Dr. Martin is a national leader a strong record of service. She is a Past-President of the American Academy of Sleep Medicine and recently received the VA’s National Health System Impact Award recognizing the impact of her research on healthcare for Veterans.

Dr. Chris Schmickl MD/PhD, is an Associate Professor and sleep medicine specialist at UC San Diego whose work centers on advancing new therapies for obstructive sleep apnea. He has received NIH, AHA, and AASM funding to lead clinical trials evaluating promising pharmacologic treatments. As Director of the Advanced Care and Electrostimulation for Sleep Apnea (ACE-OSA) Program, he provides patients with new therapy options such as hypoglossal nerve stimulation and tirzepatide, particularly for those who struggle with CPAP. His goal is to broaden effective, individualized treatment pathways for sleep apnea.